Veterinary Vaccines / Animal Health Biologicals - Size, Scale & Scope
We are not into future forecasting or crystal gazing but still will risk in sticking our necks out to spot an important trend on a potentially huge opportunity in Animal Health Industry in India.
Animal Biologicals / Veterinary Vaccines – is a huge, evolving opportunity and over next 5 years could be the most significant therapeutic segment in India. Few numbers be told first…
Currently Animal Biologicals constitute around 28% - 31%* of the overall Animal HealthCare market in India and this segment is expected to be growing at >10%# annually.
This is the traditional way of using historical data to “size the future” – and that’s where the fallacy may actually lie – at least in our opinion, as explained herein.
The current size and scale on Animal Biolgicals / Veterinary Vaccines segment does not take fully into account the following broad trends:
Rapid industrialization of the entire Livestock segment in India
Entry of International Milk Majors and an impending, expected shift to international best practices….some of it is already visible
Increased realization among progressive farmers about - disease management and prevention as a better approach and lastly
More number of diseases being taken up by Federal as well as State Govts for mass vaccinations
Future Scope of the Biologicals
Lets take a close look at each individual animal species segment:
Livestock (Cattle, Buffalo, Sheep & Goat – covered together for ease of reference)
Following Bacterial and Viral diseases are well recognized, have quality vaccines available and are routinely recommended / suggested for vaccination:
Equally big opportunity lies in the following additional and economically important diseases which needs further evaluation and quantification subject to Govt. approvals:
Swine / Pigs
Apart from FMD, Brucella and CSF which are well recognized and existing opportunities, there remain chances for:
Porcine Circo Virus
High Fever / PRRS
Detailed serological as well clinical evidences could tilt the balance and unlock these opportunities.
This is one segment where preventive vaccination is well established and vaccination schedules are quite representative of the local disease situation. However, there are still a few pockets of opportunity such as:
Infectious Bronchitis – locally relevant variants etc.
It may be time to explore / consider Vaccination Policy for Avian Influenza Vaccines. There have been sporadic outbreaks which were well controlled by Govt. authorities, however, unconfirmed reports suggest usage of autogenous vaccines.
If these reports are true then a shift to an officially approved, quality produced and locally relevant Avian Influenza vaccine would immensely benefit local poultry farmers. In our opinion, it’s a choice of supporting large, local poultry industry v/s small opportunity in exports.
Companion Animal Vaccines
Similar to Poultry segment, Companion Animal Segment also is well evolved in terms of availability and usage of all relevant vaccines and established vaccination schedules for the benefit of Pet Owners.
In our opinion, there could be 2 windows of opportunity, still in Companion Animals segment:
Vaccine for Kennel Cough (Bordetella brochiseptica) and
Full compliance by Pet Owners with the vaccination schedules recommended by the Practicing Veterinarians
If some or all of the above opportunities do come true, then the size and scale of Animal Biologicals / Veterinary Vaccines will be completely different. That’s our point on the futility of using historic data to project future market trend esp. in Veterinary Vaccines / Biologicals.
If we could dare to re-draw the graph of the Animal Biologicals in India, it may look like:
Disclaimer: This article is a purely non-scientific opinion, and the sole objective is to bring in the focus on certain economically important diseases affecting our livestock, poultry and companion animals’. A brief reference list of all the published articles quoted in this opinion, is as under. Copies of all these referred documents are available with us and can be made available to you all. This is NOT an exhaustive list of published articles on various diseases in India but only a very small sample that we have quoted:
* - 3 different published sources: a) PPT data by Mr. K S Niranjan b) PPT data by Indian Immunologicals and 3) Our own estimates / extrapolation
# - Growth rate of 10% or more is referred to by a) external….. b) our own estimates
1 – Sketchy press reports, own estimates
2 – Incidence of Infection due to IBR and Leptospirosis in Indian Dairy farms under PPP Mode by PD-ADMAS Vision 2030 document
3 - Sero-prevalence of bovine Johne's disease in buffaloes and cattle population of North India using indigenous ELISA kit based on native Mycobacterium avium subspecies paratuberculosis 'Bison type' genotype of goat origin
4 - Comp Immunol Microbiol Infect Dis. 2008 Sep;31(5):419-33. Epub 2007 Sep 12. Sero-prevalence of bovine Johne's disease in buffaloes and cattle population of North India using indigenous ELISA kit based on native Mycobacterium avium subspecies paratuberculosis 'Bison type' genotype of goat origin. Singh SV1, Singh AV, Singh R, Sharma S, Shukla N, Misra S, Singh PK, Sohal JS, Kumar H, Patil PK, Misra P, Sandhu KS
5 - Seroprevalence of bovine viral diarrhea virus antibodies in cattle and buffalo of Agra region of Uttar Pradesh (India).
Varshney Puneet1, Bhatia A K1,*, Pradhan H K2, Mishra N2, Bhatia Sandeep2. 1Department of Microbiology and Immunology, College of Veterinary Science and Animal Husbandry, U P Pandit Deen Dayal Upadhayay University of Veterinary Science and Cattle Research Centre. Mathura, (Uttar Pradesh) 2High Security Animal Disease Laboratory (HSADL), Indian Veterinary Research Institute, Bhopal, (Madhay Pradesh), INDIA
6 - Rev Sci Tech. 2000 Dec;19(3):871-6. Genomic diversity and prevalence of Rotavirus in cow and buffalo calves in northern India. Jindal SR1, Maiti NK, Oberoi MS. Tropical Animal Health and Production 2009 Vol: 41(7):1231-1239